INSIDER
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Alerts on Telegram

Congress trades and big insider sales, sent the day they're filed. Free.

Open in Telegram
Data sources

Public disclosures only. Scores flag unusual patterns and are not evidence of wrongdoing. Not investment advice.

Robinhood Chain…
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyTelegram alerts
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Alerts on Telegram

Congress trades and big insider sales, sent the day they're filed. Free.

Open in Telegram
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyTelegram alerts
Search

All disclosures

Every ingested record across SEC Form 4, 13F, House PTRs and Robinhood Chain, searchable by ticker, name or wallet address.

Results

Data sources
SEC Form 421m ago
House PTR21m ago
SEC 13F20m ago
Robinhood Chain20m ago

Results

10,258 records
Side
allbuysell
Score
any≥ 30≥ 50≥ 70
Sort
Newest disclosedNewest executedInsider ScoreValue
Include
grants & admin
ScoreActorSecuritySideValueExecutedDisclosedLagSourceEvidence
35
LM
Lo Steve MingChief Accounting Officer
REALTheRealReal, Inc.
Open-market sale
SELL$112K
8,571 sh
Nov 21, 2025Nov 21, 2025
Page 243 of 257
← PrevNext →
traded Nov 21, 2025
+0d
SEC Form 4

Evidence

35
FM
Frymire Michelle MDirector
NATLNCR Atleos Corp
Open-market sale
SELL$308K
8,786 sh
Nov 19, 2025Nov 21, 2025
traded Nov 19, 2025
+2dSEC Form 4

Evidence

35
IN
Intrator Michael NDirector, CEO and President, 10% Owner
CRWVCoreWeave, Inc.
Open-market sale · 10b5-1 plan
SELL$23K
303 sh
Nov 19, 2025Nov 21, 2025
traded Nov 19, 2025
+2dSEC Form 4

Evidence

35
LM
Lo Steve MingChief Accounting Officer
REALTheRealReal, Inc.
Open-market sale
SELL$70K
5,358 sh
Nov 21, 2025Nov 21, 2025
traded Nov 21, 2025
+0dSEC Form 4

Evidence

34
CC
Cotter Jennifer CunninghamChief Content Officer
PTONPELOTON INTERACTIVE, INC.
Open-market sale · 10b5-1 plan
SELL$874K
131.5K sh
Nov 20, 2025Nov 21, 2025
traded Nov 20, 2025
+1dSEC Form 4

Evidence

33
WL
Williams Amber LeeDirector
NWBINorthwest Bancshares, Inc.
Open-market purchase
BUY$15K
1,302 sh
Nov 21, 2025Nov 21, 2025
traded Nov 21, 2025
+0dSEC Form 4

Evidence

33
WB
Wilms BrettPresident - EMEA & Australia
BRCBRADY CORP
Open-market sale
SELL$89K
1,183 sh
Nov 19, 2025Nov 21, 2025
traded Nov 19, 2025
+2dSEC Form 4

Evidence

32
HC
Hauger CarolynDirector
VFFVillage Farms International, Inc.
Open-market sale
SELL$83K
22.0K sh
Nov 20, 2025Nov 21, 2025
traded Nov 20, 2025
+1dSEC Form 4

Evidence

32
IN
Intrator Michael NDirector, CEO and President, 10% Owner
CRWVCoreWeave, Inc.
Open-market sale · 10b5-1 plan
SELL$1.11M
14.9K sh
Nov 19, 2025Nov 21, 2025
traded Nov 19, 2025
+2dSEC Form 4

Evidence

32
LM
Lo Steve MingChief Accounting Officer
REALTheRealReal, Inc.
Open-market sale
SELL$27K
2,068 sh
Nov 21, 2025Nov 21, 2025
traded Nov 21, 2025
+0dSEC Form 4

Evidence

31
DV
Date Rajeev VDirector
CRCLCircle Internet Group, Inc.
Open-market sale
SELL$142K
2,000 sh
Nov 20, 2025Nov 21, 2025
traded Nov 20, 2025
+1dSEC Form 4

Evidence

31
CP
Clune Katherine PatriciaChief Financial Officer
PIPRPIPER SANDLER COMPANIES
Open-market sale
SELL$444K
1,367 sh
Nov 21, 2025Nov 21, 2025
traded Nov 21, 2025
+0dSEC Form 4

Evidence

31
LW
Lloyd George W.EVP, Investments & CLO
RPRXRoyalty Pharma plc
Open-market sale · 10b5-1 plan
SELL$1.83M
47.8K sh
Nov 19, 2025Nov 21, 2025
traded Nov 19, 2025
+2dSEC Form 4

Evidence

31
LW
Lloyd George W.EVP, Investments & CLO
RPRXRoyalty Pharma plc
Open-market sale · 10b5-1 plan
SELL$1.81M
47.4K sh
Nov 19, 2025Nov 21, 2025
traded Nov 19, 2025
+2dSEC Form 4

Evidence

30
HJ
Holstein JensDirector
VCYTVERACYTE, INC.
Open-market sale · 10b5-1 plan
SELL$299K
7,049 sh
Nov 20, 2025Nov 21, 2025
traded Nov 20, 2025
+1dSEC Form 4

Evidence

30
DV
Date Rajeev VDirector
CRCLCircle Internet Group, Inc.
Open-market sale
SELL$354K
5,000 sh
Nov 20, 2025Nov 21, 2025
traded Nov 20, 2025
+1dSEC Form 4

Evidence

60
GT
Green Derek ToddDirector
GLOOGloo Holdings, Inc.
Open-market purchase
BUY$2.00M
250.0K sh
Nov 20, 2025Nov 20, 2025
traded Nov 20, 2025
+0dSEC Form 4

Evidence

60
BA
Beck Scott ArthurDirector, President and CEO, 10% Owner
GLOOGloo Holdings, Inc.
Open-market purchase
BUY$3.30M
412.5K sh
Nov 20, 2025Nov 20, 2025
traded Nov 20, 2025
+0dSEC Form 4

Evidence

54
DT
Dalton TravisDirector, Pres., CEO & Executive Chair
CTEVClaritev Corp
Open-market purchase
BUY$250K
5,290 sh
Nov 20, 2025Nov 20, 2025
traded Nov 20, 2025
+0dSEC Form 4

Evidence

51
GM
Gotschall MatthewSee Remarks
GLOOGloo Holdings, Inc.
Open-market purchase
BUY$2,000
250 sh
Nov 20, 2025Nov 20, 2025
traded Nov 20, 2025
+0dSEC Form 4

Evidence

46
GT
Giordano Christopher ThomasDirector, CEO
TENXTENAX THERAPEUTICS, INC.
Open-market purchase
BUY$13K
1,612 sh
Nov 18, 2025Nov 20, 2025
traded Nov 18, 2025
+2dSEC Form 4

Evidence

43
GA
Glenn Robert AlexanderEVP & Chief Legal Officer
DUKDuke Energy CORP
Open-market sale
SELL$1.02M
8,200 sh
Nov 19, 2025Nov 20, 2025
traded Nov 19, 2025
+1dSEC Form 4

Evidence

42
RW
Rogers James WilliamChief Financial Officer
TEMTempus AI, Inc.
Open-market sale
SELL$326K
4,988 sh
Nov 18, 2025Nov 20, 2025
traded Nov 18, 2025
+2dSEC Form 4

Evidence

41
SA
Sale Hillary ADirector
WDIWestern Asset Diversified Income Fund (WDI)
Open-market purchase
BUY$20K
1,410 sh
Nov 20, 2025Nov 20, 2025
traded Nov 20, 2025
+0dSEC Form 4

Evidence

39
PE
Phelps ErikEVP & Chief Admin & Legal Off
TEMTempus AI, Inc.
Open-market sale
SELL$158K
2,428 sh
Nov 18, 2025Nov 20, 2025
traded Nov 18, 2025
+2dSEC Form 4

Evidence

39
PE
Phelps ErikEVP & Chief Admin & Legal Off
TEMTempus AI, Inc.
Open-market sale
SELL$73K
1,105 sh
Nov 18, 2025Nov 20, 2025
traded Nov 18, 2025
+2dSEC Form 4

Evidence

39
RW
Rogers James WilliamChief Financial Officer
TEMTempus AI, Inc.
Open-market sale
SELL$150K
2,269 sh
Nov 18, 2025Nov 20, 2025
traded Nov 18, 2025
+2dSEC Form 4

Evidence

38
YH
Yang HongyongVP and GM Fuel Syst. Asia Pac
PHINPHINIA INC.
Open-market sale
SELL$47K
893 sh
Nov 19, 2025Nov 20, 2025
traded Nov 19, 2025
+1dSEC Form 4

Evidence

38
GT
Giordano Christopher ThomasDirector, CEO
TENXTENAX THERAPEUTICS, INC.
Open-market purchase
BUY$3,417
455 sh
Nov 19, 2025Nov 20, 2025
traded Nov 19, 2025
+1dSEC Form 4

Evidence

38
HL
Heard Carlos LawrenceSenior Vice President & CFO
BFSSAUL CENTERS, INC.
Open-market purchase
BUY$6,165
300 sh
Nov 20, 2025Nov 20, 2025
traded Nov 20, 2025
+0dSEC Form 4

Evidence

38
FR
Fukushima RyanChief Operating Officer
TEMTempus AI, Inc.
Open-market sale
SELL$453K
6,942 sh
Nov 18, 2025Nov 20, 2025
traded Nov 18, 2025
+2dSEC Form 4

Evidence

38
LH
Litinsky James H.Director, Chairman and CEO
MPMP Materials Corp. / DE
Open-market sale
SELL$13.23M
207.7K sh
Nov 20, 2025Nov 20, 2025
traded Nov 20, 2025
+0dSEC Form 4

Evidence

38
GT
Giordano Christopher ThomasDirector, CEO
TENXTENAX THERAPEUTICS, INC.
Open-market purchase
BUY$4,083
538 sh
Nov 20, 2025Nov 20, 2025
traded Nov 20, 2025
+0dSEC Form 4

Evidence

36
PB
Pfeiffenberger BrentDirector, President and CEO
IPSCCentury Therapeutics, Inc.
Open-market purchase
BUY$17K
35.0K sh
Nov 19, 2025Nov 20, 2025
traded Nov 19, 2025
+1dSEC Form 4

Evidence

36
SS
See Tai SandiChief Development Officer
LXEOLexeo Therapeutics, Inc.
Open-market sale
SELL$3,578
386 sh
Nov 18, 2025Nov 20, 2025
traded Nov 18, 2025
+2dSEC Form 4

Evidence

36
OM
Otero Jose ManuelChief Technical Officer
LXEOLexeo Therapeutics, Inc.
Open-market sale
SELL$6,684
721 sh
Aug 18, 2025Nov 20, 2025
traded Aug 18, 2025
+94dSEC Form 4

Evidence

36
AE
Adler EricChief Medical Officer
LXEOLexeo Therapeutics, Inc.
Open-market sale
SELL$5,701
615 sh
Nov 18, 2025Nov 20, 2025
traded Nov 18, 2025
+2dSEC Form 4

Evidence

36
RJ
Robertson JennyChief Legal Officer
LXEOLexeo Therapeutics, Inc.
Open-market sale
SELL$5,089
549 sh
Nov 18, 2025Nov 20, 2025
traded Nov 18, 2025
+2dSEC Form 4

Evidence

36
TN
Townsend Richard NolanDirector, Chief Executive Officer
LXEOLexeo Therapeutics, Inc.
Open-market sale
SELL$10K
1,127 sh
Nov 18, 2025Nov 20, 2025
traded Nov 18, 2025
+2dSEC Form 4

Evidence

35
CP
Carr PatriciaSVP, Chief Accounting Officer
JAZZJazz Pharmaceuticals plc
Open-market sale
SELL$956K
5,250 sh
Nov 18, 2025Nov 20, 2025
traded Nov 18, 2025
+2dSEC Form 4

Evidence